M. Matuccicerinic et al., SOMATOSTATIN-INDUCED MODULATION OF INFLAMMATION IN EXPERIMENTAL ARTHRITIS, Arthritis and rheumatism, 38(11), 1995, pp. 1687-1693
Objective. To study the antiinflammatory effect of different doses of
intraarticular somatostatin in experimental arthritis in rabbits. Meth
ods. Chronic arthritis was induced by a single injection of fibrin int
o the knee joint of rabbits previously sensitized to this antigen. The
effects of sequential intraarticular injections of somatostatin into
the rabbit knee, at doses of 500, 750, and 1,000 mu g, were monitored
by measuring knee joint circumferences and hematologic parameters. The
measurements were compared with those obtained following use of triam
cinolone acetonide and placebo. At the end of the experiments, the kne
e joints were examined histologically. Results. Somatostatin treatment
induced a statistically significant and dose-related reduction of kne
e joint swelling. This effect was shorter than that produced by triamc
inolone acetonide; however, the antiinflammatory activity elicited by
successive doses of triamcinolone acetonide declined both in extent an
d duration, while the effects of somatostatin remained unchanged at ea
ch successive treatment. Histopathologic observations showed that both
somatostatin and triamcinolone acetonide reduced the inflammatory sig
ns in the joint structures, although triamcinolone acetonide appeared
to be more effective. Conclusion. These findings suggest that somatost
atin exerts an antiinflammatory effect in this model of experimental a
rthritis and may represent a valid and safer alternative to corticoste
roids for intraarticular therapy of arthritis.